封面
市場調查報告書
商品編碼
1455743

全球人參狗補品市場 - 2023-2030

Global Ginseng Dog Supplement Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年,全球人參狗補充劑市場達到1.2921億美元,預計2030年將達到2.0907億美元,2023-2030年預測期間CAGR為6.2%。

寵物支出成長的趨勢是包括人參狗補充劑市場在內的各種寵物補充劑成長的重要驅動力根據美國寵物產品協會APPA的數據,美國人在寵物上的支出從2021年的1236億美元增加到2022年的1368億美元. 人參狗補充劑因其天然成分和潛在的健康益處而經常被作為優質產品銷售。隨著寵物主人尋求這些優質產品,對人參狗補充劑的需求預計將會上升。

寵物主人越來越對寵物的醫療保健採取預防性方法,力求在健康問題出現之前預防它們。人參狗補充劑據稱具有增強免疫力和增強整體健康的特性,適合這種預防保健方法。製造商正在利用這一趨勢,開發人參補充劑,旨在促進狗的整體健康並預防與年齡相關的健康問題。

由於寵物狗的關節問題日益增多,關節健康佔據了一半以上的市場。同樣,由於該地區豐富的草藥歷史和人們對寵物健康意識不斷增強的推動,亞太地區在人參狗補充劑市場上佔據主導地位。以人參為基礎的療法在亞洲傳統文化中的流行以及中國、日本和韓國等國家寵物飼養率的上升,促成了亞太地區在該市場的主導地位。

動力學

寵物擁有量的增加

由於寵物數量的增加,人參狗補充劑市場正在經歷成長。根據美國寵物產品協會的2021-2022年全國寵物主人調查,6,900萬美國家庭擁有一隻狗作為寵物。隨著越來越多的人選擇歡迎狗狗進入他們的家庭,對支持這些寵物健康和福祉的產品的需求也隨之增加。

寵物主人擴大投資於為毛茸茸的同伴提供最好的護理,包括人參產品等營養補充劑。人參因其對人類的潛在健康益處而受到推崇,由於其在增強能量、增強免疫功能和促進整體健康方面的優勢,現已得到認可並融入寵物護理方案中。因此,人參狗補充劑市場正在經歷顯著成長,因為它滿足了寵物主人不斷變化的需求和偏好。

專注於天然和整體產品

對天然和整體產品的關注是人參狗補充劑市場成長的重要推動力。寵物主人擴大尋求傳統藥物的替代品,更喜歡符合他們促進寵物整體健康信念的自然療法。人參以其藥用特性和在傳統醫學中的長期使用而聞名,非常適合這個故事。

此外,人們對傳統寵物補充劑中常見的合成成分的潛在副作用的擔憂推動了向天然和整體產品的轉變。人參提供了一種天然的解決方案,吸引了那些優先考慮毛茸茸同伴的安全和福祉的寵物主人。隨著寵物主人繼續優先考慮毛茸茸的伴侶的健康和福祉,天然寵物補充劑(包括含有人參的補充劑)的市場預計將大幅成長。

潛在的健康風險和不良影響

潛在的過敏或敏感性對人參狗補充劑市場的成長構成重大限制。雖然人參通常被認為對大多數狗是安全的,但由於潛在的副作用,不應該給患有高血壓、腎臟病或心肌病變的狗服用。此外,人參可能對狗有血液稀釋作用,這對某些人來說可能是個問題

此外,大量或長期過量服用人參還會導致憂鬱、食慾不振、低血壓、過敏等不良症狀。這些潛在的風險和副作用可能會阻止寵物主人為他們的狗使用人參補充劑,特別是那些對引入新補充劑持謹慎態度或擔心寵物健康的人。

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按產品分類
  • 以狗類型分類
  • 人參類型片段
  • 按應用程式片段
  • 按配銷通路分類的片段
  • 按地區分類的片段

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 寵物擁有量的增加
      • 專注於天然和整體產品
    • 限制
      • 潛在的健康風險和不良影響
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:依產品

  • 膠囊
  • 平板電腦
  • 粉狀補充劑
  • 其他

第 8 章:按狗類型

  • 小狗
  • 成人

第 9 章:按人參類型

  • 西洋參
  • 亞洲人參
  • 其他

第 10 章:按應用

  • 關節健康
  • 免疫系統支持
  • 能量與活力
  • 皮膚和毛髮健康
  • 消化系統健康
  • 血糖管理
  • 其他

第 11 章:按配銷通路

  • 超市/大賣場
  • 網路零售
  • 專業寵物店
  • 獸醫診所
  • 其他商業

第 12 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第13章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 14 章:公司簡介

  • GIGI VET
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Animal Health Company
  • KIN DOG GOODS
  • Heilsa
  • Ray Allen Manufacturing
  • Happea Chappea Limited
  • Animaux
  • INLIFE Healthcare
  • Royal Pet
  • URANOVET, SL

第 15 章:附錄

簡介目錄
Product Code: FB8185

Overview

Global Ginseng Dog Supplement Market reached US$ 129.21 million in 2022 and is expected to reach US$ 209.07 million by 2030, growing with a CAGR of 6.2% during the forecast period 2023-2030.

The trend of growing pet expenditure is a significant driver for the growth of various pet supplements including the ginseng dog supplement market According to APPA, American Pet Products Association, The amount that Americans spend on pets increased from $123.6 billion in 2021 to $136.8 billion in 2022. Ginseng dog supplements are often marketed as premium products due to their natural ingredients, and potential health benefits. As pet owners seek out these premium offerings, the demand for ginseng dog supplements is expected to rise.

Pet owners are increasingly adopting a preventive approach to their pets' healthcare, seeking to prevent health issues before they arise. Ginseng dog supplements, with their purported immune-boosting and overall health-enhancing properties, fit into this preventive healthcare approach. Manufacturers are capitalizing on this trend by developing ginseng supplements targeted at promoting overall wellness and preventing age-related health issues in dogs.

Joint health accounts for over half of the market share due to the rising joint issues on pet dogs. Similarly, Asia-Pacific dominates the ginseng dog supplement market driven by the region's rich history of herbal medicine and growing awareness of pet health. The popularity of ginseng-based remedies in traditional Asian cultures and the rising pet ownership rates in countries like China, Japan, and South Korea contribute to the dominance of Asia-Pacific in this market.

Dynamics

Rise in Pet Ownership

The Ginseng Dog Supplement Market is experiencing growth due to the rise in pet ownership. According to the American Pet Products Association's 2021-2022 National Pet Owners Survey, 69 million U.S. households own a dog as a pet. As more individuals choose to welcome dogs into their homes and families, there is a parallel increase in the demand for products that support the health and well-being of these pets.

Pet owners are increasingly invested in providing their furry companions with the best possible care, including nutritional supplements like ginseng-based products. Ginseng, revered for its potential health benefits in humans, is now being recognized and integrated into pet care regimens due to its perceived advantages in boosting energy, enhancing immune function, and promoting overall well-being. Consequently, the ginseng dog supplement market is experiencing significant growth as it meets the evolving needs and preferences of pet owners.

Focus on Natural and Holistic Products

The focus on natural and holistic products is a significant driver behind the growth of the ginseng dog supplement market. Pet owners are increasingly seeking alternatives to traditional pharmaceuticals, preferring natural remedies that align with their beliefs in promoting overall wellness for their pets. Ginseng, known for its medicinal properties and long-standing use in traditional medicine, fits well into this narrative.

Moreover, the shift towards natural and holistic products is driven by concerns about the potential side effects of synthetic ingredients commonly found in traditional pet supplements. Ginseng offers a natural solution, appealing to pet owners who prioritize the safety and well-being of their furry companions. As pet owners continue to prioritize the health and well-being of their furry companions, the market for natural pet supplements, including those containing ginseng, is expected to grow significantly.

Potential Health Risks and Adverse Effects

Potential allergies or sensitivities pose a significant restraint to the growth of the ginseng dog supplement market. While ginseng is generally considered safe for most dogs, it should not be given to dogs with hypertension, kidney disease, or cardiomyopathy due to potential adverse effects. Additionally, ginseng may have blood-thinning effects on dogs, which can be problematic for certain individuals

Moreover, excessive use of ginseng in large quantities or over the long term can lead to adverse symptoms such as depression, loss of appetite, hypotension, and allergies. These potential risks and side effects may deter pet owners from using ginseng supplements for their dogs, particularly those who are cautious about introducing new supplements or have concerns about their pets' health.

Segment Analysis

The global ginseng dog supplement market is segmented based on product, dog type, ginseng type, application, distribution channel and region.

Prevalence of Joint Issues in Dogs

Joint health problems, such as arthritis and hip dysplasia, are common in dogs, particularly as they age. According to the IAABC Foundation Journal, Pet dogs are frequently affected by osteoarthritis (OA). 80% of dogs over 8 years old and 20 percent of dogs over 1 year old have been discovered to have some degree of osteoarthritis. As a result, there is a high demand for supplements that can support joint function and alleviate symptoms associated with these conditions.

Ginseng is believed to have anti-inflammatory properties and may help reduce joint pain and inflammation in both humans and animals. As a result, it is often included as an active ingredient in dog supplements targeting joint health. As awareness of the benefits of ginseng-based supplements spreads, particularly in addressing joint issues, the market share of this application segment increases.

Geographical Penetration

Asia-Pacific's Growing Ginseng Production

Ginseng has a long history of traditional medicinal use in many Asian cultures, including China and Korea. According to Earth Observatory, a part of the EOS Project Science Office at NASA Goddard Space Flight Center, China is the world's leading producer of ginseng. Similarly, according to the Jilin Ginseng Industry Association, 60% of China's ginseng is produced in Jilin. The Jilin ginseng industry's output value hit 64 billion yuan (8.77 billion US dollars) in 2022. With increasing ginseng production in the Asia Pacific region, there is a steady and reliable supply of ginseng and its derivatives.

Moreover, the Asia Pacific region has experienced significant growth in pet ownership, particularly in countries like China, Japan, and South Korea. According to a report released Tuesday by Pethadoop, a platform specializing in China's pet industry, China has 54 million pet dogs as of 2021. As pet owners become more invested in the health and well-being of their pets, they are increasingly seeking out supplements like ginseng to improve their pets' health.

COVID-19 Impact Analysis

With people spending more time at home due to lockdowns and remote work arrangements, there was increased attention on pet health and wellness. This led to a rise in demand for supplements, including those containing ginseng, believed to have health benefits for dogs. Pet owners seek to bolster their pets' immune systems and overall health as a preventative measure against illness, including potential viral infections. Ginseng is often touted for its immune-boosting properties, which made it particularly appealing during a health crisis like Covid-19.

However, COVID-19 has disrupted global supply chains, and affected the availability of raw materials and finished products. This could lead to shortages or delays in the production and distribution of ginseng dog supplements, impacting both manufacturers and consumers. Economic uncertainties resulting from the pandemic affected consumer spending habits. Some pet owners may cut back on non-essential expenses, including supplements, leading to a temporary decline in sales.

Russia-Ukraine War Impact Analysis

The war between Russia and Ukraine affected the supply chain for ginseng or related ingredients used in dog supplements, which led to shortages or price increases. The war led to economic uncertainty, which impacted consumer spending habits. During the war, consumers prioritized essentials over non-essential items such as pet supplements. This led to a temporary decline in demand for premium pet food including ginseng dog supplements.

By Product

  • Capsules
  • Tablets
  • Powdered Supplements
  • Others

By Dog Type

  • Puppy
  • Adult

By Ginseng Type

  • American Ginseng
  • Asian Ginseng
  • Others

By Application

  • Joint Health
  • Immune System Support
  • Energy and Vitality
  • Skin and Coat Health
  • Digestive Health
  • Blood Sugar Management
  • Others

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Online Retail
  • Specialty Pet Stores
  • Veterinary Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In October 2023, Baumann Ginseng Farm, a ginseng farm in the United States, launched a ginseng joint health supplement for pets. Lonza patent UC-II non-denatured type II collagen, 20 mg per pack, is an ingredient in this product. Along with the advantages of 150 mg of American ginseng extract, it aids in promoting metabolism, nourishing and strengthening the body, and maintaining vitality in pets. It also helps pets retain joint mobility and cartilage health.
  • In June 2022, Charmy Pet, a Canadian pet nutrition company, launched a Kickstarter campaign to launch their new range of freeze-dried pet food. Introducing a new line of freeze-dried formulas that include holistic herbs used in traditional Chinese medicine, the first of its type in North America. Charmy is assisting pet parents in enhancing their dogs' health without the need for synthetic vitamins and supplements by incorporating natural herbs from traditional Chinese medicine, such as ginseng and astragalus root, into pet food.
  • In March 2021, the Ministry of Trade, Industry and Energy and the Korea Chamber of Commerce and Industry approved a request for permission from Pet healthcare start-up Allfin to operate a customized pet food business in a regulatory sandbox. This will allow Koreans to order bowls of samgyetang, a traditional chicken soup with ginseng, for their dogs.

Competitive Landscape

The major global players in the market include GIGI VET, Animal Health Company, KIN DOG GOODS, Heilsa, Ray Allen Manufacturing, Happea Chappea Limited, Animaux, INLIFE Healthcare, Royal Pet, URANOVET, S.L.

Why Purchase the Report?

  • To visualize the global ginseng dog supplement market segmentation based on product, dog type, ginseng type, application, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ginseng dog supplement market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ginseng dog supplement market report would provide approximately 78 tables, 78 figures and 200 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product
  • 3.2.Snippet by Dog Type
  • 3.3.Snippet by Ginseng Type
  • 3.4.Snippet by Application
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.1.Rise in Pet Ownership
      • 4.1.1.1.2.Focus on Natural and Holistic Products
    • 4.1.2.Restraints
      • 4.1.2.1.1.Potential Health Risks and Adverse Effects
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2.Market Attractiveness Index, By Product
  • 7.2.Capsules*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Tablets
  • 7.4.Powdered Supplements
  • 7.5.Others

8.By Dog Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 8.1.2.Market Attractiveness Index, By Dog Type
  • 8.2.Puppy*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Adult

9.By Ginseng Type

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 9.1.2.Market Attractiveness Index, By Ginseng Type
  • 9.2.American Ginseng*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Asian Ginseng
  • 9.4.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Joint Health*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Immune System Support
  • 10.4.Energy and Vitality
  • 10.5.Skin and Coat Health
  • 10.6.Digestive Health
  • 10.7.Blood Sugar Management
  • 10.8.Others

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Supermarkets/Hypermarkets*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Online Retail
  • 11.4.Specialty Pet Stores
  • 11.5.Veterinary Clinics
  • 11.6.Others Commercial

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Spain
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1.GIGI VET*
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Animal Health Company
  • 14.3.KIN DOG GOODS
  • 14.4.Heilsa
  • 14.5.Ray Allen Manufacturing
  • 14.6.Happea Chappea Limited
  • 14.7.Animaux
  • 14.8.INLIFE Healthcare
  • 14.9.Royal Pet
  • 14.10.URANOVET, S.L.

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us